Literature DB >> 10535977

Profound misregulation of muscle-specific gene expression in facioscapulohumeral muscular dystrophy.

R Tupler1, G Perini, M A Pellegrino, M R Green.   

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disorder characterized by an insidious onset and progressive course. The disease has a frequency of about 1 in 20,000 and is transmitted in an autosomal dominant fashion with almost complete penetrance. Deletion of an integral number of tandemly arrayed 3.3-kb repeat units (D4Z4) on chromosome 4q35 is associated with FSHD but otherwise the molecular basis of the disease and its pathophysiology remain obscure. Comparison of mRNA populations between appropriate cell types can facilitate identification of genes relevant to a particular biological or pathological process. In this report, we have compared mRNA populations of FSHD and normal muscle. Unexpectedly, the dystrophic muscle displayed profound alterations in gene expression characterized by severe underexpression or overexpression of specific mRNAs. Intriguingly, many of the deregulated mRNAs are muscle specific. Our results suggest that a global misregulation of gene expression is the underlying basis for FSHD, distinguishing it from other forms of muscular dystrophy. The experimental approach used here is applicable to any genetic disorder whose pathogenic mechanism is incompletely understood.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10535977      PMCID: PMC23032          DOI: 10.1073/pnas.96.22.12650

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  Regional mapping of facioscapulohumeral muscular dystrophy gene on 4q35: combined analysis of an international consortium.

Authors:  M Sarfarazi; C Wijmenga; M Upadhyaya; B Weiffenbach; C Hyser; K Mathews; J Murray; J Gilbert; M Pericak-Vance; P Lunt
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

3.  Linkage analyses of five chromosome 4 markers localizes the facioscapulohumeral muscular dystrophy (FSHD) gene to distal 4q35.

Authors:  B Weiffenbach; R Bagley; K Falls; C Hyser; D Storvick; S J Jacobsen; P Schultz; J Mendell; K Willems van Dijk; E C Milner
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

4.  Linkage studies in facioscapulohumeral muscular dystrophy (FSHD).

Authors:  J R Gilbert; J M Stajich; M C Speer; J M Vance; C S Stewart; L H Yamaoka; F Samson; M Fardeau; T G Potter; A D Roses
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

5.  Estimation of age dependent penetrance in facioscapulohumeral muscular dystrophy by minimising ascertainment bias.

Authors:  P W Lunt; D A Compston; P S Harper
Journal:  J Med Genet       Date:  1989-12       Impact factor: 6.318

6.  Characterization of a tandemly repeated 3.3-kb KpnI unit in the facioscapulohumeral muscular dystrophy (FSHD) gene region on chromosome 4q35.

Authors:  J H Lee; K Goto; C Matsuda; K Arahata
Journal:  Muscle Nerve Suppl       Date:  1995

7.  Cloning the differences between two complex genomes.

Authors:  N Lisitsyn; N Lisitsyn; M Wigler
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

8.  Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy.

Authors:  J E Hewitt; R Lyle; L N Clark; E M Valleley; T J Wright; C Wijmenga; J C van Deutekom; F Francis; P T Sharpe; M Hofker
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Spreading the silence: epigenetic transcriptional regulation during Drosophila development.

Authors:  A Moehrle; R Paro
Journal:  Dev Genet       Date:  1994
View more
  14 in total

1.  Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts.

Authors:  Andrei Petrov; Iryna Pirozhkova; Gilles Carnac; Dalila Laoudj; Marc Lipinski; Yegor S Vassetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

Review 2.  Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?

Authors:  Mark Richards; Frédérique Coppée; Nick Thomas; Alexandra Belayew; Meena Upadhyaya
Journal:  Hum Genet       Date:  2011-10-09       Impact factor: 4.132

Review 3.  Deciphering transcription dysregulation in FSH muscular dystrophy.

Authors:  Melanie Ehrlich; Michelle Lacey
Journal:  J Hum Genet       Date:  2012-06-21       Impact factor: 3.172

4.  Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle.

Authors:  Dalila Laoudj-Chenivesse; Gilles Carnac; Catherine Bisbal; Gerald Hugon; Sandrine Bouillot; Claude Desnuelle; Yegor Vassetzky; Anne Fernandez
Journal:  J Mol Med (Berl)       Date:  2004-11-17       Impact factor: 4.599

5.  CD8(+) T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI.

Authors:  Giovanni Frisullo; Roberto Frusciante; Viviana Nociti; Giorgio Tasca; Rosaria Renna; Raffaele Iorio; Agata Katia Patanella; Elisabetta Iannaccone; Alessandro Marti; Monica Rossi; Assunta Bianco; Mauro Monforte; Pietro Attilio Tonali; Massimiliano Mirabella; Anna Paola Batocchi; Enzo Ricci
Journal:  J Clin Immunol       Date:  2010-11-10       Impact factor: 8.317

6.  DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1.

Authors:  Manjusha Dixit; Eugénie Ansseau; Alexandra Tassin; Sara Winokur; Rongye Shi; Hong Qian; Sébastien Sauvage; Christel Mattéotti; Anne M van Acker; Oberdan Leo; Denise Figlewicz; Marietta Barro; Dalila Laoudj-Chenivesse; Alexandra Belayew; Frédérique Coppée; Yi-Wen Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-05       Impact factor: 11.205

7.  Reduction of a 4q35-encoded nuclear envelope protein in muscle differentiation.

Authors:  Cecilia Ostlund; Tinglu Guan; Denise A Figlewicz; Arthur P Hays; Howard J Worman; Larry Gerace; Eric C Schirmer
Journal:  Biochem Biophys Res Commun       Date:  2009-08-28       Impact factor: 3.575

8.  A nuclear matrix attachment site in the 4q35 locus has an enhancer-blocking activity in vivo: implications for the facio-scapulo-humeral dystrophy.

Authors:  Andrei Petrov; Jeanne Allinne; Iryna Pirozhkova; Dalila Laoudj; Marc Lipinski; Yegor S Vassetzky
Journal:  Genome Res       Date:  2007-11-21       Impact factor: 9.043

9.  Cellular delivery and photochemical activation of antisense agents through a nucleobase caging strategy.

Authors:  Jeane M Govan; Rajendra Uprety; Meryl Thomas; Hrvoje Lusic; Mark O Lively; Alexander Deiters
Journal:  ACS Chem Biol       Date:  2013-08-19       Impact factor: 5.100

10.  Rbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of Facioscapulohumeral muscular dystrophy (FSHD).

Authors:  Mariaelena Pistoni; Lily Shiue; Melissa S Cline; Sergia Bortolanza; Maria Victoria Neguembor; Alexandros Xynos; Manuel Ares; Davide Gabellini
Journal:  PLoS Genet       Date:  2013-01-03       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.